Cargando…

Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease

INTRODUCTION: Late‐life onset psychosis is associated with faster progression to dementia in cognitively normal people, but little is known about its relationship with cognitive impairment in advance of dementia. METHODS: Clinical and genetic data from 2750 people ≥50 years of age without dementia w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Creese, Byron, Arathimos, Ryan, Aarsland, Dag, Ballard, Clive, Brooker, Helen, Hampshire, Adam, Corbett, Anne, Ismail, Zahinoor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150165/ https://www.ncbi.nlm.nih.gov/pubmed/37139261 http://dx.doi.org/10.1002/trc2.12386

Ejemplares similares

Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
por: Creese, Byron, et al.
Publicado: (2021)

FLAME: A computerized neuropsychological composite for trials in early dementia
por: Brooker, Helen, et al.
Publicado: (2020)

Self-harm and Suicidality Experiences of Middle-Age and Older Adults With vs. Without High Autistic Traits
por: Stewart, Gavin R., et al.
Publicado: (2022)

Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
por: Ismail, Zahinoor, et al.
Publicado: (2023)

Psychosis in Alzheimer’s Disease
por: Ballard, Clive, et al.
Publicado: (2020)

A data‐driven examination of apathy and depressive symptoms in dementia with independent replication
por: Vasconcelos Da Silva, Miguel, et al.
Publicado: (2023)

Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease
por: Creese, Byron, et al.
Publicado: (2022)

Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 Update
por: Rogowska, Marianna, et al.
Publicado: (2022)

Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease
por: Creese, Byron, et al.
Publicado: (2019)

Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status
por: Ghahremani, Maryam, et al.
Publicado: (2023)

Mental health of people living with dementia in care homes during COVID-19 pandemic
por: Velayudhan, Latha, et al.
Publicado: (2020)

Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias
por: Chai, Yuek Ling, et al.
Publicado: (2023)

International relevance of two measures of awareness of age-related change (AARC)
por: Sabatini, Serena, et al.
Publicado: (2020)

Loneliness, physical activity, and mental health during COVID-19: a longitudinal analysis of depression and anxiety in adults over the age of 50 between 2015 and 2020
por: Creese, Byron, et al.
Publicado: (2020)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Physical and mental health conditions account for variability in awareness of age-related changes
por: Sabatini, Serena, et al.
Publicado: (2023)

Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
por: Gibson, Lucy L., et al.
Publicado: (2023)

Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes
por: Mueller, Christoph, et al.
Publicado: (2020)

Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
por: Husebo, Bettina S, et al.
Publicado: (2011)

FITS into practice: translating research into practice in reducing the use of anti-psychotic medication for people with dementia living in care homes
por: Brooker, Dawn J., et al.
Publicado: (2016)

Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge
por: Cousins, Oliver, et al.
Publicado: (2023)

Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome
por: Jones, Emma L., et al.
Publicado: (2013)

Bidirectional Associations of Awareness of Age-Related Change and Attitudes Toward Own Aging With Social Media Use
por: Sabatini, Serena, et al.
Publicado: (2023)

Self-Perceptions of Aging Among Dementia Caregivers: Evidence from the UK Protect Study
por: Turner, Shelbie, et al.
Publicado: (2021)

Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms
por: McGirr, Alexander, et al.
Publicado: (2022)

Psychiatric and neuropsychiatric syndromes and COVID-19
por: Velayudhan, Latha, et al.
Publicado: (2020)

Agitation and impulsivity in mid and late life as possible risk markers for incident dementia
por: Bateman, Daniel R., et al.
Publicado: (2020)

Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial
por: Khalifa, Khadija, et al.
Publicado: (2020)

Exploring prior diseases associated with incident late-onset Alzheimer’s disease dementia
por: Liao, Jung-Yu, et al.
Publicado: (2020)

Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
por: Killick, Richard, et al.
Publicado: (2023)

Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome()
por: Mok, Kin Y., et al.
Publicado: (2014)

Development and assessment of a brief screening tool for psychosis in dementia
por: Cummings, Jeffrey L., et al.
Publicado: (2021)

Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications
por: Mueller, Christoph, et al.
Publicado: (2017)

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
por: Siepel, Françoise J, et al.
Publicado: (2013)

Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
por: Abdelnour, Carla, et al.
Publicado: (2023)

Impact of the Covid‐19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings
por: McDermid, Joanne, et al.
Publicado: (2023)

Comparing Clinical Profiles in Alzheimer's Disease and Parkinson's Disease Dementia
por: Farlow, Martin R., et al.
Publicado: (2013)

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
por: Folch, Jaume, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tglm1t39gh5f63495cbdiphrma